NRC vs. GB, TASK, UPBD, OLO, FLYW, ASTH, CRTO, EVH, RDWR, and STGW
Should you be buying National Research stock or one of its competitors? The main competitors of National Research include Global Blue Group (GB), TaskUs (TASK), Upbound Group (UPBD), OLO (OLO), Flywire (FLYW), Astrana Health (ASTH), Criteo (CRTO), Evolent Health (EVH), Radware (RDWR), and Stagwell (STGW). These companies are all part of the "business services" industry.
National Research vs. Its Competitors
National Research (NASDAQ:NRC) and Global Blue Group (NYSE:GB) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.
In the previous week, Global Blue Group had 3 more articles in the media than National Research. MarketBeat recorded 4 mentions for Global Blue Group and 1 mentions for National Research. Global Blue Group's average media sentiment score of 0.70 beat National Research's score of 0.07 indicating that Global Blue Group is being referred to more favorably in the news media.
Global Blue Group has higher revenue and earnings than National Research. National Research is trading at a lower price-to-earnings ratio than Global Blue Group, indicating that it is currently the more affordable of the two stocks.
47.3% of National Research shares are held by institutional investors. Comparatively, 89.7% of Global Blue Group shares are held by institutional investors. 8.1% of National Research shares are held by insiders. Comparatively, 5.2% of Global Blue Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
National Research has a net margin of 17.14% compared to Global Blue Group's net margin of 16.56%. National Research's return on equity of 71.33% beat Global Blue Group's return on equity.
National Research has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500. Comparatively, Global Blue Group has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500.
Global Blue Group has a consensus price target of $6.00, suggesting a potential downside of 19.68%. Given Global Blue Group's stronger consensus rating and higher probable upside, analysts clearly believe Global Blue Group is more favorable than National Research.
Summary
Global Blue Group beats National Research on 9 of the 15 factors compared between the two stocks.
Get National Research News Delivered to You Automatically
Sign up to receive the latest news and ratings for NRC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
National Research Competitors List
Related Companies and Tools
This page (NASDAQ:NRC) was last updated on 7/4/2025 by MarketBeat.com Staff